InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume $0.26 -0.01 (-3.70%) (As of 11/1/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends InMed Pharmaceuticals Short Interest DataInMed Pharmaceuticals (INM) has a short interest of 40,000 shares. This marks a -57.08% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 2.51 million shares to cover all short positions.Current Short Interest40,000 sharesPrevious Short Interest93,200 sharesChange Vs. Previous Month-57.08%Dollar Volume Sold Short$8,760.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 15, 2024Outstanding Shares13,350,000 sharesPercentage of Shares Shorted0.30%Today's Trading Volume183,444 sharesAverage Trading Volume2,511,229 sharesToday's Volume Vs. Average7% Short Selling InMed Pharmaceuticals? Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINM Short Interest Over TimeINM Days to Cover Over TimeINM Percentage of Float Shorted Over Time Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. InMed Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/202440,000 shares $8,760.00 -57.1%N/A0 $0.22 9/30/202493,200 shares $22,088.40 -82.6%N/A0 $0.24 9/15/2024534,900 shares $139,822.86 +55.3%N/A0.1 $0.26 8/31/2024344,500 shares $122,263.05 +818.7%N/A0 $0.35 8/15/202437,500 shares $5,400.00 -85.2%N/A0 $0.14 7/31/2024253,200 shares $44,512.56 +85.2%N/A0.2 $0.18 Get the Latest News and Ratings for INM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for InMed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024136,700 shares $36,457.89 +61.4%N/A0.1 $0.27 6/30/202484,700 shares $22,487.85 -43.5%N/A0.1 $0.27 6/15/2024150,000 shares $34,005.00 +252.9%N/A0.2 $0.23 5/31/202442,500 shares $12,537.50 -44.6%N/A0.1 $0.30 5/15/202476,700 shares $21,015.34 -78.6%N/A0.2 $0.27 4/30/2024359,000 shares $96,571.00 +213.5%N/A0.9 $0.27 4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32 3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36 3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36 2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42 2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35 1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36 1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38 12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42 12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36 11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44 11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41 10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48 10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64 9/30/2023900 shares $629.91 -90.1%N/A0 $0.70 9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84 8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82 8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94 7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12 7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96 6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92 6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27 5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34 5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16 4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20 4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25 3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08 3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06 2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33True paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67 1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84 1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89 12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02 12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86 11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65 11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78 10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05 10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31 9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59 9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61 8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95 8/15/20226,600 shares $2,571.36 -62.5%0.1%0 $0.39 7/31/202217,600 shares $6,864.00 -18.9%0.2%0.1 $0.39 7/15/202221,700 shares $8,029.00 +6.4%0.3%0.1 $0.37 6/30/202220,400 shares $9,596.16 -80.1%0.3%0.1 $0.47 6/15/2022102,300 shares $53,400.60 +47.6%1.3%0.5 $0.52 5/31/202269,300 shares $53,361.00 -29.4%0.9%0.3 $0.77 5/15/202298,100 shares $81,423.00 -34.3%1.3%0.5 $0.83 4/30/2022149,300 shares $135,863.00 -8.7%1.9%0.7 $0.91 4/15/2022163,600 shares $142,806.44 +34.1%2.1%0.8 $0.87 3/31/2022122,000 shares $115,009.40 +114.4%1.6%0.9 $0.94 3/15/202256,900 shares $41,024.90 -35.3%0.7%0.6 $0.72 2/28/202287,900 shares $82,819.38 +2.6%1.1%0.8 $0.94 2/15/202285,700 shares $99,412.00 -2.7%1.1%0.3 $1.16 1/31/202288,100 shares $106,601.00 -15.7%1.1%0 $1.21 1/15/2022104,500 shares $129,580.00 +74.5%1.3%0 $1.24 12/31/202159,900 shares $78,469.00 -8.4%0.8%0 $1.31 12/15/202165,400 shares $96,792.00 -56.5%0.8%0 $1.48 11/30/2021150,400 shares $285,760.00 +69.9%1.9%0.1 $1.90 11/15/202188,500 shares $118,590.00 -19.7%1.1%0 $1.34 10/29/2021110,200 shares $168,055.00 +69.3%1.4%0.2 $1.53 10/15/202165,100 shares $91,140.00 -2.5%0.8%0.1 $1.40 9/30/202166,800 shares $116,900.00 +189.2%0.8%0.3 $1.75 9/15/202123,100 shares $47,553.66 +216.4%0.3%0.2 $2.06 8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21 8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40 7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79 7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67 6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18 6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85 5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95 5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81 4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73 4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21 3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13 3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75 2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37 2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35 1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95True paradigm shift (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33 INM Short Interest - Frequently Asked Questions What is InMed Pharmaceuticals' current short interest? Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 40,000 shares of INM short. Learn More on InMed Pharmaceuticals' current short interest. Is InMed Pharmaceuticals' short interest increasing or decreasing? InMed Pharmaceuticals saw a decrease in short interest during the month of October. As of October 15th, there was short interest totaling 40,000 shares, a decrease of 57.1% from the previous total of 93,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does InMed Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Cocrystal Pharma, Inc. (0.52%), Athira Pharma, Inc. (4.41%), Finch Therapeutics Group, Inc. (2.83%), Galmed Pharmaceuticals Ltd. (1.77%), TherapeuticsMD, Inc. (0.21%), Minerva Neurosciences, Inc. (0.13%), Sol-Gel Technologies Ltd. (2.31%), Synlogic, Inc. (0.76%), GeoVax Labs, Inc. (2.70%), HCW Biologics Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short InMed Pharmaceuticals stock? Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against InMed Pharmaceuticals? A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further. How often is InMed Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies Cocrystal Pharma Short Interest Athira Pharma Short Interest Finch Therapeutics Group Short Interest Galmed Pharmaceuticals Short Interest TherapeuticsMD Short Interest Minerva Neurosciences Short Interest Sol-Gel Technologies Short Interest Synlogic Short Interest GeoVax Labs Short Interest HCW Biologics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
